Key result
Bioinformatics analysis identifies MYH6 as a key hub gene with reduced expression in ischaemic cardiomyopathy.
Why the study?
The study aimed to explore potential hub genes and pathways of ischaemic cardiomyopathy and investigate possible associated mechanisms.
Population
Microarray datasets GSE5406, GSE57338, GSE23561, GSE60993, and GSE59867 from the GEO database
Design
Bioinformatics and microarray dataset analysis
Authors
Loading...
MYH6 downregulation should not yet guide clinical decisions in heart failure; leaves open its role as biomarker or target.
p-value: p=<0.05
Bioinformatics analysis identifies MYH6 downregulation as closely associated with ischaemic cardiomyopathy and heart failure.
Chen et al. (2021) studied ischaemic cardiomyopathy (ICM). Bioinformatics analysis of microarray datasets identified MYH6 as a key hub gene for ischaemic cardiomyopathy, with significantly lower expression in patients with CAD, AMI, and heart failure (p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: